High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension
Authors:
- 1 May 2006
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 107 (9) , 3486-3488
Abstract
We studied 25 patients with myelofibrosis with myeloid metaplasia and 19 patients with secondary myelofibrosis associated with pulmonary hypertension (PH). In these 2 groups, we compared the peripheral-blood CD34 count, the clonality of granulocytes and platelets in peripheral blood, the mutational status of the JAK2 kinase gene, and the morphology of the peripheral blood and bone marrow. We found that the following were distinctive features of myelofibrosis with myeloid metaplasia but not of secondary myelofibrosis due to PH: high circulating CD34 cell count, the presence of clonal platelets and granulocytes and of peripheral-blood dacrocytes, and a JAK2 1849G>T (V617F) mutation. We conclude that these are intrinsic features of clonal progenitors present in patients with myelofibrosis due to myeloproliferative disorders and that these features are not due to the abnormal marrow architecture seen in secondary myelofibrosis.Keywords
This publication has 10 references indexed in Scilit:
- JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemiaBlood, 2005
- Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)Blood, 2005
- New Onset of Myelofibrosis in Association with Pulmonary Arterial HypertensionAnnals of Internal Medicine, 2005
- The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromesBlood, 2005
- Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteasesBlood, 2005
- Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaBlood, 2005
- Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patientsBritish Journal of Haematology, 2004
- Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietinBlood, 2003
- Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasiaBlood, 2001
- Clonality Analysis Using X-Chromosome Inactivation at the Human Androgen Receptor Gene (HUMARA): Evaluation of Large Cohorts of Patients With Chronic Myeloproliferative Diseases, Secondary Neutrophilia, and Reactive ThrombocytosisAmerican Journal of Clinical Pathology, 1999